Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,362 public trials 239 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00044954

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +41 more
Locations
  • Rocky Mountain Cancer Centers - Denver Midtown Denver, Colorado, United States
  • Florida Hospital Cancer Institute Orlando, Florida, United States
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States
View all 14 locations
View Trial Details
Completed

A Study of Galunisertib in Participants With Myelodysplastic Syndromes

NCT02008318

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dresden, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Düsseldorf, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jena, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lübeck, Germany
View all 14 locations
View Trial Details
Completed

A Study of Atezolizumab Administered Alone or in Combination With Azacitidine in Participants With Myelodysplastic Syndromes

NCT02508870

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford University Palo Alto, California, United States
  • University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
View all 15 locations
View Trial Details
Completed

Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML)

NCT02447666

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • St. Anna Kinderkrebsforschung, CHILDREN'S CANCER RESEARCH INSTITUTE Vienna, Austria
  • Hopital Universitaire des Enfants Brussels, Belgium
  • University Hospital Ghent Ghent, Belgium
  • University Hospital Motol Prague, Czechia
View all 39 locations
View Trial Details
Completed

Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant

NCT00376480

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +9 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • University of Florida Health Science Center - Gainesville Gainesville, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Children's Hospital Boston Boston, Massachusetts, United States
View Trial Details
Completed

A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q

NCT01029262

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +2 more
Locations
  • University of California at Los Angeles Los Angeles, California, United States
  • Southern Illinois Hematology Oncology Centralia, Illinois, United States
  • Dartmouth Hitchcock Medical Center Norris Cotton Cancer Center Lebanon, New Hampshire, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View all 99 locations
View Trial Details
Completed

Dose-escalation Study of Oral Administration of S 055746 in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome

NCT02920541

Conditions
Acute Myeloid Leukaemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • The Alfred Hospital Melbourne, Australia
  • Royal Melbourne Hospital Parkville, Australia
  • Institut Paoli Calmettes Marseille, France
  • Hôpital Saint Louis Paris, France
View Trial Details

Related conditions